Enabling Precision Medicine for Childhood Epilepsy

News   Apr 12, 2017 | Original story from NIH/National Institute of Neurological Disorders and Stroke

 
Enabling Precision Medicine for Childhood Epilepsy
 
 
 
 

RELATED NEWS

Academic Redesigns FDA-Approved MabThera to Treat ALS

News

Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.

READ MORE

Fathers' Brains Respond Differently to Daughters Than Sons

News

Brain scans and recordings of the parents’ daily interactions with their kids suggest fathers with toddler daughters are more attentive and responsive to those daughters’ needs than fathers with toddler sons.

READ MORE

Biogen's MS Drug FAMPYRA Granted Standard Marketing Authorization in EU

News

Biogen's drug FAMPYRA improves walking for MS sufferers and has been granted standard marketing authorization.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE